These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33643836)

  • 1. Virucidal activity of oral care products against SARS-CoV-2
    Komine A; Yamaguchi E; Okamoto N; Yamamoto K
    J Oral Maxillofac Surg Med Pathol; 2021 Jul; 33(4):475-477. PubMed ID: 33643836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX
    Koch-Heier J; Hoffmann H; Schindler M; Lussi A; Planz O
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virucidal Activity of Different Mouthwashes Using a Novel Biochemical Assay.
    Rodríguez-Casanovas HJ; la Rosa M; Bello-Lemus Y; Rasperini G; Acosta-Hoyos AJ
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
    Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
    [No Abstract]   [Full Text] [Related]  

  • 6. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
    Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
    Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 0.05% cetylpyridinium chloride mouthwash as an adjunct to toothbrushing compared with 0.12% chlorhexidine gluconate mouthwash in reducing dental plaque and gingival inflammation: A randomized control trial.
    Oo MMT; Oo PH; Saddki N
    Int J Dent Hyg; 2023 Feb; 21(1):195-202. PubMed ID: 35946123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
    D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
    Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2.
    Okamoto N; Saito A; Okabayashi T; Komine A
    J Oral Maxillofac Surg Med Pathol; 2022 Nov; 34(6):800-804. PubMed ID: 35441076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro.
    Rius-Salvador M; García-Múrria MJ; Rusu L; Bañó-Polo M; León R; Geller R; Mingarro I; Martinez-Gil L
    PLoS One; 2024; 19(2):e0297291. PubMed ID: 38363760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
    Alemany A; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Ouchi D; Laporte-Villar C; Baro B; Henríquez N; Prat N; Gianinetto MO; Gutiérrez MV; Sánchez-Paniagua MG; Henríquez NL; Vicente JM; Ara J; Rodriguez-Arias MA; Puig J; Blanco I; Lopez CC; Hernández Á; Bordoy AE; Redondo CE; Soler VG; Giménez M; Blanc V; León R; Gispert J; ; Clotet B; Izquierdo-Useros N; Mitjà O
    J Dent Res; 2022 Nov; 101(12):1450-1456. PubMed ID: 35727681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
    Chen MH; Chang PC
    J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
    Brunello G; Wolf V; Kerberger R; Bernhard M; Lübke N; Becker J; Schwarz-Herzke B; Timm J; Becker K
    J Clin Periodontol; 2024 Feb; 51(2):158-166. PubMed ID: 38058254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.
    Onozuka D; Takatera S; Matsuo H; Yoshida H; Hamaguchi S; Yamamoto S; Sada RM; Suzuki K; Konishi K; Kutsuna S
    BMC Oral Health; 2024 Apr; 24(1):491. PubMed ID: 38664718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects.
    Li Y; Xie Z; Chen L; Liu X; Li S; Ye S; Tang H; Lee C; Gu Q; Men F; Zhang J; Hu D; Jiang Y; Wang X; Wang Q; Feng Y; Niu S; Liu Y; Fang Y
    Fundam Clin Pharmacol; 2024 Jun; 38(3):579-587. PubMed ID: 37985697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
    Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
    PeerJ; 2023; 11():e15080. PubMed ID: 38130922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
    Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
    Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mouthwashes on reducing SARS-CoV-2 viral load in oral cavity: a systematic review and meta-analysis.
    Ebrahimi T; Shamshiri AR; Alebouyeh M; Mohebbi SZ
    BMC Oral Health; 2023 Jul; 23(1):443. PubMed ID: 37400836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of toothpaste on the propensity of chlorhexidine and cetyl pyridinium chloride to produce staining in vitro: a possible predictor of inactivation.
    Sheen S; Owens J; Addy M
    J Clin Periodontol; 2001 Jan; 28(1):46-51. PubMed ID: 11142666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.